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Abstract
Background: Patients with borderline personality disorder (BPD) experience significant affect regulation difficulties
that cause serious consequences in their work, emotional, and social environments. This dysfunctional pattern also
produces great suffering and a heavy burden on their relatives. Fortunately, some studies show that treatment of
relatives of people with BPD begins to be important in the patients’ recovery and in improving family dynamics.
One of the treatments that has obtained the most empirical support is Family connections (FC). This 12-session
program is an adaptation of different Dialectical Behavior Therapy strategies. To test the efficacy of FC, five
uncontrolled clinical trials were conducted, with pre-post treatment and follow-up assessments. The results of these
studies and subsequent replications showed an improvement in family attitudes and caregiver burnout. Our
research team adapted FC for delivery in the Spanish population. We intend to test the efficacy of this program
versus a treatment as usual condition. Moreover, we aim to test the efficacy of this program and study its
effectiveness (in terms of participants’ acceptance). This paper presents the study protocol.
Methods: The study is a randomized controlled trial. The participants will be recruited in a Personality Disorders
Unit and randomly assigned to one of two treatment conditions: Family Connections group (FC) or Treatment As
Usual (TAU). Primary outcome measures will be the BAS and FAD-GFS. Secondary outcomes will include DASS-21,
FES, GS, and QLI. Participants’ treatment acceptance and degree of satisfaction will also be measured. Participants
will be assessed at pre-, post-treatment, and 6-month follow-up. Intention to treat and per protocol analyses will be
performed.
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Discussion: This is the first study on FC for relatives of people with borderline personality disorder (BPD) compared
to an active condition (TAU), and this is the first time relatives’ and patients’ data will be analyzed. In addition, it is
the first study to test the efficacy of the program in Spain. This intervention could contribute to improving the
efficiency and effectiveness of current treatment programs for relatives of people with BPD, help to decrease
burden, and improve the family connection.
Trial registration: ClinicalTrials.gov ID: NCT04160871. Registered November 15th 2019.
Keywords: Borderline personality disorder, Family connections, Relatives, DBT, Intervention, Caregivers, Burden
Background
Borderline personality disorder (BPD) is one of the most
challenging and complex mental disorders. BPD is re-
lated to high suicide and self-harm rates. Persistent sui-
cidal behavior is described in 69–80% of people with
BPD [1]. A longitudinal study across 24 years comparing
BPD and other personality disorders found that a total
of 5.9% of BPD sufferers died by suicide and 14% by
other causes, compared to 1.4 and 5.5% in a sample of
people with other personality disorders [2]. BPD also in-
volves high rates of hospital admissions and health ser-
vice use. BPD is associated with a high economic burden
due to the long-term use of health services [3–6], in-
cluding interventions in emergency settings and the
need for the services of several different professionals
[6–8]. Furthermore, BPD is an important public mental
health problem that produces great suffering for patients
and their relatives [9]. For this reason, there is a need to
provide specialized care.
The symptoms of BPD and their consequences lead to
high levels of discomfort and burden for their relatives
[10–14]. Additionally, there is evidence that maladaptive
family communication patterns play a role in the eti-
ology and maintenance of BPD [14, 15].
Family members of people with BPD are more likely
to have psychological problems [16, 17], and they de-
scribe feelings of confusion, lack of awareness, and in-
competence [14, 18, 19]. Studies with relatives of people
with BPD showed that the levels of burden and depres-
sion can increase due to lack of clear knowledge about
the diagnosis and the evolution of the disorder [19, 20].
Moreover, when family members participate in treat-
ment, patient relapse decreases, recovery is easier, and
wellbeing in the family improves [20, 21].
Currently, there are interventions for family members
with empirical support. All these programs are offered
in group format, but they differ in the type of orientation
and contents. So far, two of these studies present only
psychoeducational contents; one is based on mentaliza-
tion [22], and the other combines cognitive analytical
therapy with general psychiatric care [23]. Regarding the
programs that offer skills training, almost all are DBT-
based programs or DBT adaptations. These DBT skills
training studies have different structures and numbers of
sessions. They use either adaptations of DBT in 10–12
sessions where parents receive training in DBT mini-
skills [17, 24–27] or group therapy where skills are
taught for 6 months [28].
Family Connections (FC) is the most empirically sup-
ported program [25] for relatives of patients with BPD.
The program can be carried out by clinicians or trained
relatives. To date, five uncontrolled clinical trials have
been performed with pre- and post-treatment and
follow-up assessments [17, 24, 25, 29, 30]. In all the rep-
lications, the results of the FC program were consistent,
showing significant decreases in burden, grief, anxiety,
and depression, and significant increases in the partici-
pants’ subjective experience of mastery, empowerment,
well-being variables, and family functioning. Further-
more, these variations were maintained or improved at
3- or 6-month follow up. The good results for family
functioning could be due to the fact that FC validates
patients’ skillful behaviors, decreases their psychological
symptoms, improves interpersonal relationships between
family members and patients, increases understanding of
the problem, reduces perceived stigma, and enhances
family empowerment [30].
FC is a program for relatives of people with BPD that
was developed within the National Education Alliance
for Borderline Personality Disorder [17, 25]. This pro-
gram links three important needs for relatives: first, edu-
cation about the disorder and family functioning;
second, individual and family skills to manage negative
reactions in the family and improve well-being in the re-
lationship; and, finally, social support from other rela-
tives participating in the same group who have had very
similar experiences [17].
A pilot study by Hoffman et al. [25], with pre-, post-,
and 6-month follow-up of one group, suggests that this
program promotes significant reductions in grief and
burden and a significant increase in mastery. A replica-
tion and extension study of FC by Hoffman et al. [17],
with a pre-, post-, and 3-month follow-up of one group,
shows improvements in well-being variables and depres-
sion. Another descriptive mixed study (qualitative and
quantitative data) with two groups (family members with
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and without clinically relevant symptoms) showed that
the subgroup with clinically relevant symptoms had a
significant decrease in depression and anxiety symptoms
at follow-up, and women showed a decrease in both
anxiety and depression symptoms before and after the
intervention [29]. Flynn et al. [24] found similar results
in a non-randomized controlled study (pre-, post-, 3-,
12-, or 19-month follow-up) that compared FC with a
psychoeducation group. Finally, in a non-randomized
comparison study with pre-, post-, and 6-month follow-
up assessments, participants who received FC reported
fewer mental health difficulties, a lower perceived bur-
den of caring, and higher overall family functioning [30].
Therefore, considerable progress has been made in this
line of work, which had not previously been considered.
However, it would be desirable to advance in this direc-
tion by comparing FC to active treatments in larger sam-
ples and, if possible, examine the impact of the
treatment on both family members and patients. An-
other important issue is the dissemination of FC to other
cultural contexts. This study will provide the first effi-
cacy data on the comparison of FC with an active treat-
ment condition in a randomized controlled trial.
Another contribution of this study is the measurement
of the evolution of the family climate in relation to the
improvements of both relatives and patients. Finally, this
is the first study on FC carried out in a Spanish-speaking
population.
This study has several objectives. First, we aim to test
the efficacy of FC for relatives of patients with BDP in
an RCT with a sample of participants from specialized
care in Spain, compared to Treatment as Usual (TAU),
that is, an active treatment condition. Second, we will
study the feasibility and acceptance of this intervention
protocol in family members of patients with BPD. Third,
we intend to study whether changes in family members’
disease burden and clinical symptoms are related to the
improvements observed in patients with BPD. Fourth,
we aim to study whether the changes that may occur in
relatives with regard to disease burden and clinical
symptoms are related to the family climate. Finally, we
will study the perceptions and opinions of families and
patients about both intervention protocols.
We hypothesize that: a) both interventions will result in
significant reductions in distress and burden and improve-
ments in overall family functioning at post-treatment, and
these results will be maintained at the 6-month follow-up;
b) the FC program will significantly outperform the TAU
intervention on measures of subjective burden, validation
skills, family functioning, and quality of life; c) both proto-
cols will be well accepted, but FC will be rated significantly
higher by the participants; d) the improvement that may
occur in the family members with regard to disease bur-
den and clinical symptoms will have a positive influence
on the family climate; e) in an exploratory way, given the
lack of specific data in the literature, we hypothesize that
the changes observed in the relatives will be related to the




We will conduct a two-armed randomized controlled
trial (RCT). Participants will be randomly assigned to
one of two conditions: Family Connections (FC) or
Treatment As Usual (TAU). Block randomization will be
carried out among the three clinical centers, considering
that if a patient has more than one family member who
attends the group, they will be randomized together to
be included in the same condition. Measures will be
taken before starting the intervention, after the interven-
tion, and at the 6-month follow-up to determine
whether improvements after the intervention are main-
tained in the long term. The study flowchart appears in
Fig. 1. We will follow the CONSORT statement (Consol-
idated Standards of Reporting Trials, http://www.con-
sort-statement.org) [31, 32] and the SPIRIT guidelines
(Standard Protocol Items: Recommendations for Inter-
ventional Trials) [33, 34].
Sample size
To determine the sample size, the effect sizes found in
the literature on the subject have been considered. The
controlled study by Grenyer et al. [35], which tested a
group psychoeducation protocol for caregivers of people
with BPD, reported medium to large effect sizes (dyadic
adjustment, d = .78; family empowerment, d = 1.4). In
addition, on measures of burden, Grenyer [35] reported
significant improvements between post assessment and
the 12-month follow-up, with medium effect sizes (Bur-
den Assessment Scale, d = .45). These effects are consist-
ent with the literature on psychological treatments for
other psychiatric disorders, such as the meta-analysis of
psychological interventions for caregivers of people with
bipolar disorders (Burden, g = −.80) [36].
Taking these data into account, in the present
study, adopting a conservative approach, an effect size
of 0.60 is expected because our design includes two
experimental conditions. Considering an alpha of 0.05
and a statistical power of 0.80 on a 2-tailed t test, the
total sample size needed to reach an effect size of
0.60 for burden is 90 participants (45 participants per
experimental condition). To control the maximum
possible loss of participants during treatment, based
on the literature about programs for family members
of patients with BPD, a 29% dropout rate is expected
[20, 23–25, 27]. Thus, the required sample size
should be a total of 116 participants (58 participants
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per group). These calculations were made with the
software program G*Power 3.1 [37].
Study population, recruitment, and eligibility criteria
The sample will consist of relatives of people with BPD.
Recruitment will be carried out among relatives of pa-
tients treated at clinical centers specializing in the treat-
ment of BPD in the Valencian region. Inclusion criteria
will include the following: a) being 18 years old or more;
b) having a family member diagnosed with BPD; c) abil-
ity to understand and read Spanish; and d) providing
written informed consent. Participants will be recruited
by clinicians working in these clinical centers in three
Spanish cities (Castellón, Valencia, and Alicante), until
the required sample is complete. Clinicians will offer pa-
tients’ families the opportunity to participate in the
study and, after explaining it, obtain their informed con-
sent. All the psychologists who participate in this re-
search will have at least a master’s degree in Clinical
Psychology and specialized FC training.
A psychologist will contact the participant to deter-
mine his/her inclusion in the study. At that time, the re-
searcher will collect the baseline data and determine
whether the inclusion criteria are met (see Table 1).
Then the psychologist will contact a person outside the
research group who will perform the individual
randomization and inform the assessor of a code that
corresponds to the type of treatment. This psychologist
will be unaware of the characteristics of the study.
The psychologist will ensure that the participant has
understood the characteristics of the study, and he/she
will answer any questions the participant has. Partici-
pants will agree (or not) to participate before knowing
which intervention condition they will be assigned to.
The participants will also be informed that they can
leave the study whenever they wish, and that in no case
will there be any negative consequences for their family
member who is receiving treatment at the center.
The psychologists who will participate in this study
have extensive experience in implementing the DBT
program for patients and will receive training in the FC
program.
Ethics
The study will follow the Declaration of Helsinki Guide-
lines and existing guidelines in Spain and the European
Union for the protection of participants in clinical trials.
The Ethics Committee of the University of Valencia
Fig. 1 Flowchart of the study
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(Valencia, Spain) has approved this study. The trial was
registered at clinicalstrial.gov as NCT04160871, regis-
tered the 15th of November of 2019.
Sample recruitment will be carried out by qualified cli-
nicians. Researchers will explain the study to the partici-
pants, and they will sign the consent form as volunteer
participants with the possibility of dropping out at any
time. If our hypotheses are confirmed, the FC condition
will be offered to participants assigned to the TAU con-
dition after the 6-month follow-up. Special difficulties
are not expected, based on the literature. If a participant
drops out of the trial due to unwanted events, s/he will
have the opportunity to participate the next time the
treatment groups for family members are offered.
To protect information, personal data (e.g. age, sex,
address, mail, phone) will be collected by the researchers
participating in this study, and data will be replaced by
codes. Personal data will be strictly separated from other
data, and it will only be available to researchers respon-
sible for the study, always considering and protecting
the right to privacy of the participants.
Interventions
We translated the FC protocol for relatives of people
with BPD into Spanish. It is one of the first programs
designed to be applied directly to relatives of patients
with BPD. The program is an adaptation of different
Dialectical Behavior Therapy strategies, one of the most
researched and empirically supported treatments for
BPD people [24, 38]. It is composed of six modules di-
vided into 12 sessions lasting approximately 2 h each.
The intervention protocol is structured in a caregiver
handbook [25]. In the following section, the modules in
each treatment program are briefly described.
The FC protocol includes components aimed primarily
at reducing distress and burden and improving overall
family functioning: relationship mindfulness skills, family
environment skills, validation skills, and problem man-
agement skills. Furthermore, the program includes Psy-
choeducation about borderline personality disorder.
Family connections (FC)
This intervention program consists of six modules with
two sessions each, designed to improve family attitudes
and reduce family exhaustion. Each module has specific
objectives and practical exercises, as well as videos with
examples of people suffering from BPD and their
relatives:
1. Introduction. The objective of this module is to
provide information about the aims of the program,
weekly format and guidelines, statement of rights,
and criteria and symptoms of BPD. The central role
of emotion regulation is also presented.
2. Family Education. The purpose of this module is to
present treatment programs for BPD and comorbid
disorders, biosocial factors related to the etiology of
the disorder, the difficulties BPD provokes in the
family members, and the need for help. It also
shows the transactional model of the development
of BPD and related disorders.
3. Relationship Mindfulness Skills. This module aims
to define a validating family environment, being
mindful of the relationship, emotion regulation
skills, and states of mind.
4. Family Environment Skills. The aim is to
understand the relationship between the individual
and the family’s welfare, the importance of
Table 1 Study measures and evaluation times
Participant Measure Aim Evaluation time
Caregiver S-D Interview Diagnosis BL
BAS Severity of burden symptoms BL, Post-T and FU
FAD-GFS Familiar Global Functioning BL, Post-T and FU
DASS-21 Depression, anxiety and stress symptoms BL, Post-T and FU
FES Family empowerment BL, Post-T and FU
QLI-Sp Quality of life BL, Post-T and FU
OTSM Treatment opinion and acceptance PM
Patient FAD-GFS Familiar Global Functioning BL, Post-T and FU
DASS-21 Depression, anxiety and stress symptoms BL, Post-T and FU
DERS Difficulties in emotional regulation BL, Post-T and FU
LEAP Emotional availability of parents BL, Post-T and FU
VIRS Validating and invalidating responses BL, Post-T and FU
BL Baseline; Post-T Post-treatment; FU 6-month follow up; OTSM Opinion of Treatment Scale by Modules; S-D interview Socio-Demographic Interview; BAS Burden
Assessment Scale; FAD-GFS Family Assessment Device – Global Functioning Scale; DASS-21 Depression, Anxiety and Stress Scale; DERS Difficulties in Emotion
Regulation; FES Family Empowerment Scale; QLI-SP Quality Life Inventory-Spanish version; GS Grief Scale; LEAP Lum Emotional Availability of Parents; VIRS
Validating and Invalidating Responses Scale
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maladaptive ways of thinking related to blame, and
the concept of radical acceptance.
5. Validation Skills. The objective of this module is to
understand what validation means and learn
validation and self-validation skills. Moreover, in
this module, the relatives learn how to set clear
limits and achieve self-respect.
6. Problem Management Skills. This module focuses
on interpersonal efficacy, defining problems and
solutions, and problem management skills.
Adaptation to Spanish
The FC program has been translated into Spanish by the
Puerto Rican research group directed by Dr. Domingo
Marqués, and adapted to the Spanish spoken in Spain by
our research team. This translation was performed by
clinical experts who were familiar with both DBT [39, 40]
and the FC program. The translation included the FC pro-
gram manual, as well as the videos that accompany the
program (they were subtitled in Spanish) and the bro-
chures, leaflets, and handouts.
Treatment as usual (TAU)
Treatment as usual is the program routinely offered to
BPD patients’ relatives in the clinical centers participat-
ing in this trial. The intervention includes 12 therapeutic
sessions in six modules. Each module has specific objec-
tives and practical exercises.
1. Introduction. This module consists of an overview
of the treatment and the aims of the group.
Furthermore, it focuses on the definition of
personality disorders, BPD and its clinical
characteristics, the role of emotion regulation, and
comorbid disorders.
2. Family Education. The aim of this module is to
explain the diagnostic criteria for BPD, associated
problems (alcohol and substance use and eating
disorders), the DBT model, and the main goals of
the treatment.
3. Validation Skills. The purpose of this module is to
explain what validating and invalidating
environments are, the consequences of an
invalidating environment, and how to use validating
skills.
4. Crisis Management Skills. This module aims to
prevent crises by explaining how to manage anger
and learning how to act in the presence of self-
injuring and suicidal behaviors. Moreover, accept-
ance skills are shown in this module.
5. Problem Management Skills. This module helps the
relative to know how to deal with problems and set
clear limits, handle conflict in everyday situations,
confront unacceptable behavior, and manage
emotionally charged conversations.
6. Relapse Prevention. It aims to strengthen the
strategies learned throughout the program,
schedule future practice, and teach the participants
how to identify and cope with future high-risk
situations.
Measures
Table 1 presents a summary of the measures.
Caregiver measures (participants)
Sociodemographic interview
Demographic variables questionnaire: age, family con-
stellation, sex, educational level, income, marital status,
number / age of children, and psychiatric history.
Primary outcomes
Burden assessment scale (BAS) [41]
It consists of 19 items that assess the caregivers’ object-
ive and subjective burden in the past 6 months. Items
are rated on a 4-point Likert scale ranging from 1 to 4,
and higher values indicate a heavier burden. Internal re-
liability of the scale ranges from .89 to .91, and it shows
adequate validity [42]. This scale is not validated in
Spanish and it will be an objective of this work.
Family assessment device – global functioning scale (FAD-
GFS) [43]
It is a self-report questionnaire consisting of 60 items re-
lated to family functioning. It is composed of seven sub-
scales: Problem-Solving, Communication, Roles,
Affective Responsiveness, Affective Involvement, Behav-
ior Control, and General Functioning. Cronbach’s alphas
range from .72 to .83 for the subscales, and.92 for gen-
eral functioning, and test-retest reliabilities for the FAD
scales were adequate [44]. This scale is not validated in
Spanish and it will be an objective of this work.
Secondary outcomes
Depression, anxiety and stress scale (DASS-21) [45]
This scale has 42 items about negative emotional
symptoms. They proposed a short version with 21
items. The DASS-21 showed good factor structures.
Regarding the internal consistency, Cronbach’s alphas
were excellent for the DASS-21 subscales: Depression
(α = .94), Anxiety (α = .87), and Stress (α = .91) [46].
We used the Spanish version validated by Daza, Novy,
Stanley and Averill [47].
Family empowerment scale (FES) [48]
It consists of 34 items divided into three subscales: fam-
ily, service system, and involvement in community,
which refer to three forms of empowerment: attitudes,
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knowledge, and behaviors. Items are rated on a scale
from 1 to 5, and higher scores indicate a greater sense of
empowerment. The psychometric properties are the fol-
lowing: regarding the internal consistency of the FES
subscales, the coefficients ranged from .87 to .88, and
validity and reliability were adequate. This scale is not
validated in Spanish and it will be an objective of this
work.
Quality of life index-Spanish version (QLI-Sp) [49]
This index consists of 10 items that assess perceived
quality of life, including physical and emotional well-
being, self-care and independent functioning, occupa-
tional and interpersonal functioning, social-emotional
and community support, personal and spiritual fulfill-
ment, and a global perception of quality of life.
Higher scores indicate higher quality of life. This in-
strument has good psychometric properties, with a
Cronbach’s alpha of .89 and high test–retest reliability
(r = 0.87).
Opinion of treatment scale by modules (OTSM)
The Opinion of Treatment Scale by Modules is an in-
strument developed by our research team and adapted
from Borkovec and Nau [50]. It is designed to assess
the participants’ opinion and acceptance of the pro-
gram. Furthermore, it evaluates the level of change
obtained with regard to the therapeutic modules.
Questions involve how logical the treatment seemed,
degree of satisfaction, if they would recommend the
program, if they think this program would be useful
to treat their problems or others, and expectations
about the program. It evaluates the six treatment
modules in the two conditions. There are two sub-
scales: one evaluates the learning of the skills taught
in the module and is rated from 0 (not at all) to 10
(a lot), and the other evaluates how the module has
helped the caregiver to improve several aspects, such
as knowing and understanding the problem, under-
standing emotions, mindfulness of the relationship
with their relative, acceptance, family atmosphere, and
problem solving, and it is rated from 1 (not at all) to
4 (a lot). Additionally, there is an expectation ques-
tion only at the end of the first module, where the
participants answer the question: “In general, what
expectations do you have about the program?”
Patient measures
Sociodemographic interview
Family Assessment Device – Global Functioning Scale
(FAD-GFS) [43].
Depression, Anxiety and Stress Scale (DASS-21)
[45].
Difficulties in emotion regulation scale – Spanish version
(DERS) [51]
The authors adapted the scale to spanish and they re-
duced the items from 36 to 28 with five subscales: emo-
tional lack of control, life interference, lack of emotional
attention, emotional confusion, and emotional rejection.
All the items have a Likert type design, with a score be-
tween 1 and 5, where 1 means “Hardly Ever” and 4
“Usually”, where higher score means more difficulties.
Internal consistency was excellent (α = .93) and good
test-retest reliability (pl = .74, p < .001).
Lum emotional availability of parents (LEAP) [52]
It consists of 15 items that measure mothers’ and fa-
thers’ emotional availability perceived by the patient.
Items are rated on a 6-point Likert scale ranging from 1
(never) to 6 (always). Internal consistency was excellent
in a non-clinical sample for the mother form (α = .96)
and the father form (α = .97); and in a clinical sample,
for the mother form (α = .92) and the father form
(α = .93). This instrument has adequate test–retest reli-
ability for the mother form (r = .92) and the father form
(r = .85). This scale is not validated in Spanish and it will
be an objective of this work.
Validating and invalidating responses scale (VIRS) [53]
The Validating and Invalidating Responses Scale is a 16-
item self-report that evaluates levels of validation and in-
validation of caregivers’ responses. This instrument has
two subscales: validation and invalidation responses.
These two subscales are moderately correlated. Items
are rated on a 5-point Likert scale, ranging from 0
(never) to 4 (almost all the time), and higher scores indi-
cate more perceived validation or invalidation from the
caregiver who is assessed. There are no psychometric
properties available on the VIRS yet. This scale is not
validated in Spanish and it will be an objective of this
work.
Study measures and evaluation times are summarized
in Table 1.
Data analyses
In order to analyze whether there are differences be-
tween the experimental conditions before the application
of the treatment, Student’s t tests will be performed for
the continuous variables, and chi-square tests for the
categorical variables. To compare the effectiveness of the
two treatment conditions, we will perform a multivariate
analysis of variance for repeated measures (MANOVA)
for the variables with subscales, and ANOVA for the sin-
gle variables, taking the pretreatment, posttreatment and
follow-up moments as within-subject factor and the
treatment condition (FC vs TAU) as between-subject
factor.
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Moreover, between-group changes will be computed
by calculating standardized effect sizes (Cohen’s d). Fi-
nally, we will perform zero-order correlations and linear
regression analyses between the measures of the care-
givers and the measures of the patients.
Because the trial is still going on, the state of the art in
analytic methodology for RCT will be reviewed before
analyzing the data, and so variations in the selection of
the most appropriate analytic procedures may occur.
Discussion
FC is an intervention program for relatives of people
with BPD that has been adapted to Spanish by our re-
search team. FC was designed to train relatives of people
with BPD to improve global family functioning, em-
powerment, resilience, validation, and mindfulness skills,
and decrease grief, burden, hopelessness, and psycho-
logical symptoms [25].
The first aim of this study is to provide data from an
RCT about the efficacy of this intervention protocol in a
Spanish sample of participants consisting of family
members of patients with BPD who are treated at clin-
ical centers specializing in the treatment of this disorder,
compared to an active condition (TAU). A second ob-
jective is to study the acceptability (expectations and
opinions) of this program among the participants. An-
other aim is to analyze whether there are changes in rel-
atives’ burden and psychological symptoms related to
the improvement observed in patients. The fourth aim
consists of studying whether these changes are related to
the family climate. Finally, we will examine the opinions
and perceptions of relatives and patients about both
intervention protocols.
The study aims to contribute to the existing literature
on the efficacy and effectiveness of intervention pro-
grams for relatives of BPD patients, specifically FC. In
addition, it aims to assess whether the improvements ob-
tained in the relatives are related to those obtained by
the patients themselves. Moreover, this study will help
to facilitate access to this type of intervention for
Spanish-speaking people, which is important due to the
lack of options for many people who suffer from this
problem, not only in Spain, but also in many countries
in South America, in the United States, or in other
countries with a significant number of Spanish-speaking
citizens. The study will offer data that can be compared
to those obtained in other studies carried out in English-
speaking countries.
The data obtained in this study can be compared to
results obtained in studies with DBT skills protocol pro-
grams for relatives. Several studies have found improve-
ments in mental health patients’ relatives and the
relationship with their loved ones, but further research is
needed. One of the aims of this study is to examine the
effect of the treatment components on increasing global
family functioning and decreasing burden and distress,
which will mean an important change in the research
and treatment of relatives of people with BPD. To our
knowledge, this is the first RCT study to compare FC to
an active condition (TAU) and include a 6-month
follow-up.
An important aim of the study is to identify methods
to improve access to FC, as well as providing psycho-
logical support to everyone who needs it. We are living
in a new era in the field of personality disorders, where
BPD is given more and more attention. Researchers and
clinicians are already crossing the barriers of traditional
classifications and treatments, and we can now use these
new protocols with significant and encouraging results.
The use of the treatment in group format (a more cost-
effective format than individual therapy) can help to dis-
seminate and increase the access to these family
interventions.
To conclude, in this study, the effectiveness of the ap-
plication of the FC program will be tested by measuring
the acceptability of this program and each specific mod-
ule in relatives of patients with BPD.
An important strength of this study is that it is the
first RCT of FC compared to an active intervention, and
it is carried out in a routine clinical care context, an eco-
logical setting. If the hypotheses are confirmed, we ex-
pect a fast implementation of FC in these centers and
other similar settings. It is also the first study carried out
in a Spanish-speaking population, thus facilitating the
dissemination of the program in other Spanish-speaking
countries or populations.
However, this study has some limitations. We do
not expect to have recruitment difficulties because
our research team collaborates with different clinical
centers, but even so we would have liked to increase
the number of centers participating in the study. This
was not possible for funding and logistic reasons. An-
other limitation is that we included a follow-up at 6
months. We would have liked to carry out a long-
term follow-up, but due to the conditions of the cen-
ters, it is difficult to contact relatives or patients who
leave treatment or are discharged.
Finally, the aim of this study is to contribute to the
literature on the efficacy of the FC program for rela-
tives of people with BPD. We hope that this study
contributes to the exploration of the efficacy and ac-
ceptability of programs designed to improve global
family functioning and reduce family members’ bur-
den. It will also contribute to improving our under-
standing of the relationships that may exist between
the clinical evolution of the family members receiving
the program and the evolution of the patients. If sig-
nificant results are achieved, there will be an effect
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on the design and application of future family inter-
vention programs, as a way to improve the overall
functioning of the family climate and reduce the bur-
den and distress they face. Finally, this study will
allow the possible application of the program to
Spanish-speaking populations in other countries.
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